Submitted by: Submitted by HexaReport
Views: 10
Words: 1010
Pages: 5
Category: Business and Industry
Date Submitted: 07/07/2016 12:54 AM
Hexa Reports
Market Research Reports and Insightful Company Profiles
Metastatic Hormone Refractory (Castration Resistant,
Androgen-Independent) Prostate Cancer Market Size,
Share, Global Analysis, Trends, Outlook, Overview, Market
Insights, Pipeline Review, H1 2016
Summary
Global Markets Direct's, 'Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent)
Prostate Cancer - Pipeline Review, H1 2016', provides an overview of the Metastatic Hormone
Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Metastatic
Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer, complete with
analysis by stage of development, drug target, mechanism of action (MoA), route of administration
(RoA) and molecule type.
Browse Detail Report With TOC @ http://hexareports.com/report/metastatic-hormone-refractorycastration-resistant-androgen-independent-prostate-cancer-pipeline-review-h1-2016/details
The report also covers the descriptive pharmacological action of the therapeutics, its complete research
and development history and latest news and press releases. Additionally, the report provides an
overview of key players involved in therapeutic development for Metastatic Hormone Refractory
(Castration Resistant, Androgen-Independent) Prostate Cancer and features dormant and discontinued
projects.
Hexa Reports
Market Research Reports and Insightful Company Profiles
Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy
areas and nearly 3,000 indications. The report is built using data and information sourced from Global
Markets Direct's proprietary databases, company/university websites, clinical trial registries,
conferences, SEC filings, investor presentations and featured press releases from company/university
sites and industry-specific third party sources.
Drug...